Ketamine Completed Phase 2 Trials for Major Depressive Disorder (MDD) / Treatment Resistant Depression (TRD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00768430Optimization of IV Ketamine for Treatment Resistant Depression
NCT02078817Ketamine in Adolescents With Treatment-Resistant Depression
NCT01627782A Study of Ketamine in Patients With Treatment-resistant Depression
NCT01920555Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)